Literature DB >> 30066427

Evaluation of the Paris System in atypical urinary cytology.

P Mikou1, M Lenos1, D Papaioannou2, K Vrettou1, E-A Trigka3, S Sousouris1, C Constantinides4.   

Abstract

OBJECTIVE: Our aim was to evaluate the Paris System for reporting urinary cytology, especially in the field of atypia.
METHODS: During the last year, 104 urinary cases had atypical cytology. These cases were reviewed and reclassified by three cytopathologists using the Paris criteria. Cyto-histological correlation was performed in 47 cases. Additionally, all cytology diagnoses were correlated with double immunocytochemistry for p53 and CK20 result. Interobserver consistency was also evaluated.
RESULTS: Out of 104 atypical cases, 30 were classified as benign, 49 atypical and 25 suspicious for high-grade urothelial carcinoma (HGUC). Diagnostic consistency between the three observers reached 93.27%. Using the new criteria, only 47.1% of the cases remained in the atypical category. The rate of HGUC histology was 14.3%, 26.7% and 96% in the benign, atypical and suspicious for HGUC cytological categories, respectively. Immunocytochemistry positivity was observed in 25.9%, 41.8% and 80% of the cases in the three diagnostic groups.
CONCLUSIONS: The Paris System for reporting urinary cytology provides clear, easy to adopt criteria, which lead to diagnostic categories with clinical significance, facilitating patient management decisions.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer; classification; cytology; immunocytochemistry; urine

Mesh:

Year:  2018        PMID: 30066427     DOI: 10.1111/cyt.12585

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  3 in total

1.  Impact of the Paris system for reporting urine cytopathology on predictive values of the equivocal diagnostic categories and interobserver agreement.

Authors:  Rania Bakkar; James Mirocha; Xuemo Fan; David P Frishberg; Mariza de Peralta-Venturina; Jing Zhai; Shikha Bose
Journal:  Cytojournal       Date:  2019-10-22       Impact factor: 2.091

Review 2.  The Paris System for Reporting Urinary Cytology: A Meta-Analysis.

Authors:  Ilias P Nikas; Svenja Seide; Tanja Proctor; Zoi Kleinaki; Maria Kleinaki; Jordan P Reynolds
Journal:  J Pers Med       Date:  2022-01-27

3.  Usefulness of the Urine Methylation Test (Bladder EpiCheck®) in Follow-Up Patients with Non-Muscle Invasive Bladder Cancer and Cytological Diagnosis of Atypical Urothelial Cells-An Institutional Study.

Authors:  Karla B Peña; Francesc Riu; Anna Hernandez; Carmen Guilarte; Joan Badia; David Parada
Journal:  J Clin Med       Date:  2022-07-03       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.